Literature DB >> 21324898

HDAC3 and HDAC7 have opposite effects on osteoclast differentiation.

Lan Pham1, Bria Kaiser, Amanda Romsa, Toni Schwarz, Raj Gopalakrishnan, Eric D Jensen, Kim C Mansky.   

Abstract

Histone deacetylases (HDACs) are negative regulators of transcription. Endochondral bone formation including chondrocyte and osteoblast maturation is regulated by HDACs. Very little is known about the role HDACs play in osteoclast differentiation. It has been previously reported that HDAC inhibitors, trichostatin A and sodium butyrate, suppress osteoclast differentiation through multiple mechanisms. In this study, we report that suppression of HDAC3 expression similar to HDAC inhibitors inhibits osteoclast differentiation, whereas osteoclasts suppressed for HDAC7 expression had accelerated differentiation when compared with control cells. Mitf, a transcription factor, is necessary for osteoclast differentiation. We demonstrate that Mitf and HDAC7 interact in RAW 264 cells and osteoclasts. The transcriptional activity of Mitf is repressed by HDAC7. Lastly, we show that either the amino or the carboxyl terminus of HDAC7 is sufficient for transcriptional repression and that the repression of HDAC7 is insensitive to trichostatin A, indicating that HDAC7 represses Mitf at least in part by deacetylation-independent mechanism.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21324898      PMCID: PMC3069409          DOI: 10.1074/jbc.M110.216853

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  The microphthalmia transcription factor (MITF) contains two N-terminal domains required for transactivation of osteoclast target promoters and rescue of mi mutant osteoclasts.

Authors:  Kim C Mansky; Kavita Marfatia; Georgia H Purdom; Alex Luchin; David A Hume; Michael C Ostrowski
Journal:  J Leukoc Biol       Date:  2002-02       Impact factor: 4.962

2.  Repression of Runx2 function by TGF-beta through recruitment of class II histone deacetylases by Smad3.

Authors:  Jong Seok Kang; Tamara Alliston; Rachel Delston; Rik Derynck
Journal:  EMBO J       Date:  2005-06-30       Impact factor: 11.598

3.  Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts.

Authors:  Hiroshi Takayanagi; Sunhwa Kim; Takako Koga; Hiroshi Nishina; Masashi Isshiki; Hiroki Yoshida; Akio Saiura; Miho Isobe; Taeko Yokochi; Jun-ichiro Inoue; Erwin F Wagner; Tak W Mak; Tatsuhiko Kodama; Tadatsugu Taniguchi
Journal:  Dev Cell       Date:  2002-12       Impact factor: 12.270

4.  Human HDAC7 histone deacetylase activity is associated with HDAC3 in vivo.

Authors:  W Fischle; F Dequiedt; M Fillion; M J Hendzel; W Voelter; E Verdin
Journal:  J Biol Chem       Date:  2001-07-20       Impact factor: 5.157

5.  microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family.

Authors:  T J Hemesath; E Steingrímsson; G McGill; M J Hansen; J Vaught; C A Hodgkinson; H Arnheiter; N G Copeland; N A Jenkins; D E Fisher
Journal:  Genes Dev       Date:  1994-11-15       Impact factor: 11.361

6.  Microphthalmia transcription factor is a target of the p38 MAPK pathway in response to receptor activator of NF-kappa B ligand signaling.

Authors:  Kim C Mansky; Uma Sankar; Jiahuai Han; Michael C Ostrowski
Journal:  J Biol Chem       Date:  2002-01-15       Impact factor: 5.157

Review 7.  RANKL-RANK signaling in osteoclastogenesis and bone disease.

Authors:  Teiji Wada; Tomoki Nakashima; Nishina Hiroshi; Josef M Penninger
Journal:  Trends Mol Med       Date:  2005-12-13       Impact factor: 11.951

8.  Histone deacetylase 3 interacts with runx2 to repress the osteocalcin promoter and regulate osteoblast differentiation.

Authors:  Tania M Schroeder; Rachel A Kahler; Xiaodong Li; Jennifer J Westendorf
Journal:  J Biol Chem       Date:  2004-08-02       Impact factor: 5.157

9.  Histone deacetylase 3 depletion in osteo/chondroprogenitor cells decreases bone density and increases marrow fat.

Authors:  David F Razidlo; Tiffany J Whitney; Michelle E Casper; Meghan E McGee-Lawrence; Bridget A Stensgard; Xiaodong Li; Frank J Secreto; Sarah K Knutson; Scott W Hiebert; Jennifer J Westendorf
Journal:  PLoS One       Date:  2010-07-09       Impact factor: 3.240

Review 10.  Mitf and Tfe3: members of a b-HLH-ZIP transcription factor family essential for osteoclast development and function.

Authors:  Christine L Hershey; David E Fisher
Journal:  Bone       Date:  2004-04       Impact factor: 4.398

View more
  37 in total

Review 1.  Hdac-mediated control of endochondral and intramembranous ossification.

Authors:  Elizabeth W Bradley; Meghan E McGee-Lawrence; Jennifer J Westendorf
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2011       Impact factor: 1.807

Review 2.  Histone Deacetylases in Bone Development and Skeletal Disorders.

Authors:  Elizabeth W Bradley; Lomeli R Carpio; Andre J van Wijnen; Meghan E McGee-Lawrence; Jennifer J Westendorf
Journal:  Physiol Rev       Date:  2015-10       Impact factor: 37.312

Review 3.  Chromatin modifiers and histone modifications in bone formation, regeneration, and therapeutic intervention for bone-related disease.

Authors:  Jonathan A R Gordon; Janet L Stein; Jennifer J Westendorf; Andre J van Wijnen
Journal:  Bone       Date:  2015-03-31       Impact factor: 4.398

4.  Protein kinase D promotes in vitro osteoclast differentiation and fusion.

Authors:  Kim C Mansky; Eric D Jensen; Julia Davidova; Masato Yamamoto; Rajaram Gopalakrishnan
Journal:  J Biol Chem       Date:  2013-02-21       Impact factor: 5.157

Review 5.  Epigenetics and Bone Remodeling.

Authors:  Ali Husain; Matlock A Jeffries
Journal:  Curr Osteoporos Rep       Date:  2017-10       Impact factor: 5.096

6.  Coordinated expression of p300 and HDAC3 upregulates histone acetylation during dentinogenesis.

Authors:  Huangheng Tao; Qiuhui Li; Yuxiu Lin; Huanyan Zuo; Yu Cui; Shuo Chen; Zhi Chen; Huan Liu
Journal:  J Cell Biochem       Date:  2019-11-06       Impact factor: 4.429

7.  Hdac3 regulates bone modeling by suppressing osteoclast responsiveness to RANKL.

Authors:  David H H Molstad; Anna M Mattson; Dana L Begun; Jennifer J Westendorf; Elizabeth W Bradley
Journal:  J Biol Chem       Date:  2020-10-04       Impact factor: 5.157

8.  HDAC7 inhibits osteoclastogenesis by reversing RANKL-triggered β-catenin switch.

Authors:  Zixue Jin; Wei Wei; Paul C Dechow; Yihong Wan
Journal:  Mol Endocrinol       Date:  2012-11-30

Review 9.  Epigenetic regulation of inflammation: progressing from broad acting histone deacetylase (HDAC) inhibitors to targeting specific HDACs.

Authors:  Melissa D Cantley; David R Haynes
Journal:  Inflammopharmacology       Date:  2013-01-23       Impact factor: 4.473

10.  HDAC3 Is a Master Regulator of mTEC Development.

Authors:  Yael Goldfarb; Noam Kadouri; Ben Levi; Asaf Sela; Yonatan Herzig; Ronald N Cohen; Anthony N Hollenberg; Jakub Abramson
Journal:  Cell Rep       Date:  2016-04-07       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.